UniProt ID | NR2F6_HUMAN | |
---|---|---|
UniProt AC | P10588 | |
Protein Name | Nuclear receptor subfamily 2 group F member 6 | |
Gene Name | NR2F6 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 404 | |
Subcellular Localization | Nucleus . | |
Protein Description | Transcription factor predominantly involved in transcriptional repression. Binds to promoter/enhancer response elements that contain the imperfect 5'-AGGTCA-3' direct or inverted repeats with various spacings which are also recognized by other nuclear hormone receptors. Involved in modulation of hormonal responses. Represses transcriptional activity of the lutropin-choriogonadotropic hormone receptor/LHCGR gene, the renin/REN gene and the oxytocin-neurophysin/OXT gene. Represses the triiodothyronine-dependent and -independent transcriptional activity of the thyroid hormone receptor gene in a cell type-specific manner. The corepressing function towards thyroid hormone receptor beta/THRB involves at least in part the inhibition of THRB binding to triiodothyronine response elements (TREs) by NR2F6. Inhibits NFATC transcription factor DNA binding and subsequently its transcriptional activity. Acts as transcriptional repressor of IL-17 expression in Th-17 differentiated CD4(+) T cells and may be involved in induction and/or maintenance of peripheral immunological tolerance and autoimmunity. Involved in development of forebrain circadian clock; is required early in the development of the locus coeruleus (LC).. | |
Protein Sequence | MAMVTGGWGGPGGDTNGVDKAGGYPRAAEDDSASPPGAASDAEPGDEERPGLQVDCVVCGDKSSGKHYGVFTCEGCKSFFKRSIRRNLSYTCRSNRDCQIDQHHRNQCQYCRLKKCFRVGMRKEAVQRGRIPHSLPGAVAASSGSPPGSALAAVASGGDLFPGQPVSELIAQLLRAEPYPAAAGRFGAGGGAAGAVLGIDNVCELAARLLFSTVEWARHAPFFPELPVADQVALLRLSWSELFVLNAAQAALPLHTAPLLAAAGLHAAPMAAERAVAFMDQVRAFQEQVDKLGRLQVDSAEYGCLKAIALFTPDACGLSDPAHVESLQEKAQVALTEYVRAQYPSQPQRFGRLLLRLPALRAVPASLISQLFFMRLVGKTPIETLIRDMLLSGSTFNWPYGSGQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | Phosphorylation | ---MAMVTGGWGGPG ---CCCCCCCCCCCC | 19.52 | 23401153 | |
15 | Phosphorylation | WGGPGGDTNGVDKAG CCCCCCCCCCCCCCC | 36.83 | 23401153 | |
32 | Phosphorylation | PRAAEDDSASPPGAA CCCCCCCCCCCCCCC | 42.86 | 30278072 | |
34 | Phosphorylation | AAEDDSASPPGAASD CCCCCCCCCCCCCCC | 35.26 | 23401153 | |
40 | Phosphorylation | ASPPGAASDAEPGDE CCCCCCCCCCCCCCC | 36.50 | 23401153 | |
83 | Phosphorylation | CKSFFKRSIRRNLSY HHHHHHHHHHHHHCH | 22.49 | 10713182 | |
89 | Phosphorylation | RSIRRNLSYTCRSNR HHHHHHHCHHCCCCC | 23.19 | 27251275 | |
110 | Phosphorylation | HHRNQCQYCRLKKCF HHHHHHHHHHHHHHH | 6.28 | 28152594 | |
134 | Phosphorylation | QRGRIPHSLPGAVAA HCCCCCCCCCCCHHH | 30.79 | 27174698 | |
142 | Phosphorylation | LPGAVAASSGSPPGS CCCCHHHCCCCCCHH | 26.04 | 20068231 | |
143 | Phosphorylation | PGAVAASSGSPPGSA CCCHHHCCCCCCHHH | 38.27 | 20068231 | |
145 | Phosphorylation | AVAASSGSPPGSALA CHHHCCCCCCHHHHH | 29.84 | 29496963 | |
149 | Phosphorylation | SSGSPPGSALAAVAS CCCCCCHHHHHHHHC | 26.36 | 20068231 | |
156 | Phosphorylation | SALAAVASGGDLFPG HHHHHHHCCCCCCCC | 36.39 | 27174698 | |
167 | Phosphorylation | LFPGQPVSELIAQLL CCCCCCHHHHHHHHH | 33.11 | 20068231 | |
291 | Ubiquitination | AFQEQVDKLGRLQVD HHHHHHHHHCCCCCC | 54.72 | 21906983 | |
330 | Ubiquitination | HVESLQEKAQVALTE HHHHHHHHHHHHHHH | 31.03 | - | |
336 | Phosphorylation | EKAQVALTEYVRAQY HHHHHHHHHHHHHHC | 18.61 | 20068231 | |
338 | Phosphorylation | AQVALTEYVRAQYPS HHHHHHHHHHHHCCC | 7.04 | 20068231 | |
343 | Phosphorylation | TEYVRAQYPSQPQRF HHHHHHHCCCCCCHH | 12.13 | 24043423 | |
345 | Phosphorylation | YVRAQYPSQPQRFGR HHHHHCCCCCCHHHH | 49.94 | 24043423 | |
379 | Ubiquitination | FFMRLVGKTPIETLI HHHHHHCCCCHHHHH | 43.58 | 21906983 | |
380 | Phosphorylation | FMRLVGKTPIETLIR HHHHHCCCCHHHHHH | 24.46 | - | |
384 | Phosphorylation | VGKTPIETLIRDMLL HCCCCHHHHHHHHHH | 28.36 | - | |
392 | Phosphorylation | LIRDMLLSGSTFNWP HHHHHHHHCCCCCCC | 27.08 | - |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NR2F6_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NR2F6_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NCOA1_HUMAN | NCOA1 | physical | 10713182 | |
GCR_HUMAN | NR3C1 | physical | 10713182 | |
THB_HUMAN | THRB | physical | 10713182 | |
ESR1_HUMAN | ESR1 | physical | 10713182 | |
COT2_HUMAN | NR2F2 | physical | 15604093 | |
NP1L1_HUMAN | NAP1L1 | physical | 20195357 | |
CBX1_HUMAN | CBX1 | physical | 20195357 | |
BC11A_HUMAN | BCL11A | physical | 23975195 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-34 AND SER-40, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-40, AND MASSSPECTROMETRY. | |
"The nuclear orphan receptor NR2F6 suppresses lymphocyte activationand T helper 17-dependent autoimmunity."; Hermann-Kleiter N., Gruber T., Lutz-Nicoladoni C., Thuille N.,Fresser F., Labi V., Schiefermeier N., Warnecke M., Huber L.,Villunger A., Eichele G., Kaminski S., Baier G.; Immunity 29:205-216(2008). Cited for: FUNCTION, SUBCELLULAR LOCATION, AND PHOSPHORYLATION AT SER-83. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-34, AND MASSSPECTROMETRY. |